The Atrial fibrillation Better Care (ABC) pathway for integrated management provides a simple strategy (Avoid stroke, Better symptom management, and Cardiovascular and comorbidity risk reduction) that helps to improve awareness and detection, and reminds clinicians of the simple decision-making steps for management of patients with atrial fibrillation in a holistic approach.
This is a preview of subscription content, log in via an institution to check access.
References
Lip, G. Y. H. et al. Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making. Thromb. Haemost. 117, 1230–1239 (2017).
Thrall, G. et al. Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest 132, 1259–1264 (2007).
Gallagher, C. et al. Integrated care in atrial fibrillation: a systematic review and meta-analysis. Heart http://dx.doi.org/10.1136/heartjnl-2016-310952 (2017).
Apostolakis, S. et al. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2 score. Chest 144, 1555–1563 (2013).
Azoulay, L. et al. Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes. Eur. Heart J. 35, 1881–1887 (2014).
Lip, G. Y. et al. Relationship of the SAMe-TT2R2 score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation. Chest 146, 719–726 (2014).
Kalman, J. M. et al. Should we perform catheter ablation for asymptomatic atrial fibrillation? Circulation 136, 490–499 (2017).
Van Gelder, I. C. et al. Lenient versus strict rate control in patients with atrial fibrillation. N. Engl. J. Med. 362, 1363–1373 (2010).
Clarkesmith, D. E. et al. Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial. PLoS ONE 8, e74037 (2013).
Raparelli, V. et al. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants. Thromb. Haemost. 117, 209–218 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author has been a consultant for Bayer/Janssen, Biotronik, Boehringer Ingelheim, Bristol-Myers Squibb (BMS)/Pfizer, Daiichi-Sankyo, Medtronic, Novartis, and Verseon; and a speaker for Bayer, BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, and Medtronic. No fees are received personally.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Lip, G. The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol 14, 627–628 (2017). https://doi.org/10.1038/nrcardio.2017.153
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2017.153
- Springer Nature Limited
This article is cited by
-
Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry
BMC Medicine (2024)
-
Pharmacist-led intervention for older people with atrial fibrillation in long-term care (PIVOTALL study): a randomised pilot and feasibility study
BMC Geriatrics (2024)
-
Systolic blood pressure visit-to-visit variability and outcomes in Asian patients with atrial fibrillation
Hypertension Research (2024)
-
Association between brachial-ankle pulse wave velocity and the risk of new-onset atrial fibrillation: A report from Kailuan prospective cohort study
npj Cardiovascular Health (2024)
-
Time in target range of systolic blood pressure and clinical outcomes in atrial fibrillation patients: results of the COOL-AF registry
Scientific Reports (2024)